The Asia Pacific point of care diagnostics market is expected to reach USD 16.73 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with a rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of point of care (PoC) products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expected to be key market factors.
The rapidly growing use of point of care diagnostic products has introduced a decentralization trend in the overall healthcare industry. Healthcare facilities and patients, in an attempt to attain or cater medical facilities remotely, encourage early diagnosis and curb costs are now decentralizing their facilities. Furthermore, these trends have also triggered the establishment of remote and stand-alone diagnostic facilities.
This product will be delivered within 1-3 business days.
The rapidly growing use of point of care diagnostic products has introduced a decentralization trend in the overall healthcare industry. Healthcare facilities and patients, in an attempt to attain or cater medical facilities remotely, encourage early diagnosis and curb costs are now decentralizing their facilities. Furthermore, these trends have also triggered the establishment of remote and stand-alone diagnostic facilities.
Asia Pacific Point Of Care Diagnostics Market Report Highlights
- The infectious diseases segment dominated the market with the highest revenue share in 2023 owing to the increasing adoption of point of care diagnostics as a substitute for traditional laboratory testing in infectious diseases applications.
- The cancer markers segment is expected to grow at the fastest CAGR over the forecast period from 2024 to 2030. The Asia Pacific region has experienced a notable rise in the prevalence of cancer in recent years.
- Glucose testing dominated the market accounting for around 20% of the revenue share in 2023 owing to the high prevalence of diabetes in Asian countries.
- The clinics segment held the largest revenue share in 2023. Clinics are essential in providing healthcare services, particularly in remote and underserved areas.
- China dominated the Asia Pacific point of care diagnostics market with a revenue share of over 41.5% in 2023. China has the world's largest population and faces notable challenges related to the prevalence of chronic and infectious diseases within its borders resulting in an increasing demand for point-of-care diagnostics.
The leading players in the Asia Pacific Point of Care Diagnostics market include:
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare GmbH
- Danaher Corporation
- Becton Dickinson (BD)
- bioMérieux
- Abbott
- Qiagen
- Werfen
- Nova Biomedical
- Trividia Health, Inc.
- SEKISUI MEDICAL CO., LTD.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Asia Pacific Point of Care Diagnostics Market Variables, Trends, & Scope
Chapter 4. Asia Pacific Point of Care Diagnostics Market: Product Estimates & Trend Analysis
Chapter 5. Asia Pacific Point of Care Diagnostics Market: End Use Estimates & Trend Analysis
Chapter 6. Asia Pacific Point of Care Diagnostics Market: Regional Estimates & Trend Analysis
Chapter 7. Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Asia Pacific Point of Care Diagnostics market include:- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare GmbH
- Danaher Corporation
- Becton Dickinson (BD)
- bioMérieux
- Abbott
- Qiagen
- Werfen
- Nova Biomedical
- Trividia Health, Inc.
- SEKISUI MEDICAL CO., LTD.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 70 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 9.31 Billion |
| Forecasted Market Value ( USD | $ 16.73 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 12 |
